on The Charcot-Marie-Tooth Association
CMTA Welcomes Patricia Verduin, PhD, to Board of Directors
The Charcot-Marie-Tooth Association (CMTA) announced the appointment of Patricia Verduin, PhD, to its Board of Directors. Verduin, a seasoned expert in science, technology, and sustainability, brings a wealth of experience from her roles in multiple Fortune 500 companies, including her significant tenure as Chief Science Officer at Colgate Palmolive. This appointment aims to further strengthen CMTA’s leadership in research and support for Charcot-Marie-Tooth disease (CMT).
With her impressive background, combining technical expertise and business acumen, Verduin is set to enhance CMTA’s efforts in accelerating research and improving support within the CMT community. “I am honored to join CMTA's Board of Directors," said Verduin. She expressed her eagerness to contribute to the organization's mission of advancing research and enhancing the quality of life for those affected by CMT.
Gilles Bouchard, Chairman of the CMTA Board, praised Verduin’s dedication to global health and her role in driving innovation that improves health and environmental well-being. “Her expertise... will greatly enhance our efforts,” Bouchard noted, emphasizing the positive impact Verduin is expected to make in the ongoing fight against CMT.
R. E.Copyright © 2024 FinanzWire, all reproduction and representation rights reserved. Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Charcot-Marie-Tooth Association news